14-day Premium Trial Subscription Sign Up For FreeGet Free

Esperion Therapeutics Stock Forecast NASDAQ:ESPR

$9.14 (-1.72%)

Volume: 830k

Closed: Oct 15, 2021

Hollow Logo Score: -7.891

Esperion Therapeutics Stock Forecast

$9.14 (-1.72%)

Volume: 830k

Closed: Oct 15, 2021

Score Hollow Logo -7.891

Esperion Therapeutics Stock Price (Quote) NASDAQ:ESPR

$9.14 ( -1.72% ) Friday, 15th Oct 2021

Range Low Price High Price Comment
30 days $9.10 $13.14 Friday, 15th Oct 2021 ESPR stock ended at $9.14. This is 1.72% less than the trading day before Thursday, 14th Oct 2021. During the day the stock fluctuated 4.29% from a day low at $9.10 to a day high of $9.49.
90 days $9.10 $18.22
52 weeks $9.10 $39.50

Historical Esperion Therapeutics prices

Date Open High Low Close Volume
2021-10-15 $9.34 $9.49 $9.10 $9.14 829 902
2021-10-14 $10.02 $10.09 $9.21 $9.30 2 674 609
2021-10-13 $10.30 $10.68 $10.21 $10.40 553 431
2021-10-12 $10.19 $10.59 $10.16 $10.30 515 586
2021-10-11 $10.38 $10.39 $10.05 $10.14 343 565
2021-10-08 $10.08 $10.46 $10.00 $10.24 712 589
2021-10-07 $10.13 $10.59 $9.99 $10.15 725 997
2021-10-06 $10.54 $10.59 $10.08 $10.17 770 410
2021-10-05 $11.72 $11.91 $10.53 $10.54 1 508 184
2021-10-04 $11.79 $11.92 $11.55 $11.73 1 018 832
2021-10-01 $12.00 $12.15 $11.69 $11.92 619 657
2021-09-30 $12.44 $12.50 $11.97 $12.05 390 463
2021-09-29 $12.67 $13.14 $12.39 $12.44 562 120
2021-09-28 $12.38 $13.07 $12.21 $12.62 541 078
2021-09-27 $11.71 $12.47 $11.47 $12.34 695 386
2021-09-24 $12.03 $12.27 $11.56 $11.58 526 572
2021-09-23 $11.82 $12.15 $11.51 $12.10 470 591
2021-09-22 $12.50 $13.02 $11.76 $11.88 1 170 747
2021-09-21 $12.47 $12.93 $12.35 $12.92 707 946
2021-09-20 $12.10 $12.59 $11.81 $12.46 859 174
2021-09-17 $12.15 $12.78 $12.10 $12.49 3 514 354
2021-09-16 $11.39 $12.10 $11.09 $12.09 937 838
2021-09-15 $11.54 $11.56 $11.14 $11.34 1 130 176
2021-09-14 $11.35 $12.14 $10.99 $11.59 1 378 115
2021-09-13 $11.82 $11.85 $11.12 $11.38 1 333 936
2021-09-10 $12.19 $12.19 $11.54 $11.81 1 347 922
2021-09-09 $11.60 $12.24 $11.48 $12.00 825 949
2021-09-08 $12.00 $12.14 $11.57 $11.61 741 106
2021-09-07 $12.77 $12.77 $11.86 $11.97 998 662
2021-09-03 $12.98 $13.10 $12.52 $12.55 675 643
2021-09-02 $13.19 $13.34 $12.84 $13.09 527 660
2021-09-01 $13.16 $13.33 $12.89 $13.17 445 693
2021-08-31 $12.80 $13.33 $12.64 $13.02 475 619
2021-08-30 $13.70 $14.00 $12.84 $12.87 1 125 434
2021-08-27 $13.11 $13.80 $13.06 $13.64 634 243
2021-08-26 $13.62 $14.06 $13.12 $13.21 415 775
2021-08-25 $13.61 $13.84 $13.28 $13.65 283 335
2021-08-24 $13.82 $14.00 $13.41 $13.60 267 620
2021-08-23 $13.42 $14.28 $13.30 $13.81 506 842
2021-08-20 $13.29 $13.58 $12.90 $13.17 468 669
2021-08-19 $13.50 $13.98 $13.01 $13.14 623 789
2021-08-18 $14.27 $14.42 $13.55 $13.58 426 085
2021-08-17 $13.84 $14.40 $13.60 $14.26 414 973
2021-08-16 $13.89 $14.35 $13.82 $13.87 463 334
2021-08-13 $14.37 $14.78 $13.84 $13.91 533 412
2021-08-12 $14.08 $14.56 $13.81 $14.52 521 904
2021-08-11 $14.08 $14.70 $14.00 $14.08 438 357
2021-08-10 $14.15 $14.15 $13.69 $14.03 500 911
2021-08-09 $14.24 $14.68 $13.92 $14.03 488 161
2021-08-06 $15.00 $15.05 $13.63 $14.21 854 896

About Esperion Therapeutics

Esperion Therapeutics Esperion Therapeutics, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of oral and low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of patients with elevated LDL-C. Its lead product candidate is ETC-1002 or Bempedoic acid, an inhibitor of ATP Citrate Lyase, an enzyme on the cholesterol biosynthesis pathway that is in Phase III long-term safety and tolerability study to... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT